1-piperidino-3-(4'-octylphenyl)-propane-3-one-hydrochloride, a new peripheral and coronary vasodilator.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001158:Arteries; D001341:Autonomic Nervous System / Q000187:drug effects; D001775:Blood Circulation / Q000187:drug effects; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000037:antagonists & inhibitors; D002746:Chlorpromazine / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects; D006099:Granuloma / Q000517:prevention & control; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006591:Hexobarbital / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007659:Ketones / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009132:Muscles / Q000494:pharmacology; D009541:Nictitating Membrane / Q000187:drug effects; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010208:Papaverine / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D014599:Uterus / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D001786:Blood Glucose; D000697:Central Nervous System Stimulants; D006634:Histamine H1 Antagonists; D007659:Ketones; D010880:Piperidines; D014665:Vasodilator Agents; D010121:Oxytocin; D006591:Hexobarbital; D010208:Papaverine; D011299:Prenylamine; D000109:Acetylcholine; D002746:Chlorpromazine; D004837:Epinephrine